Adult mice inoculated with Semliki Forest virus (SFV) were protected from a lethal infection of the central nervous system by intranasal administration of defective-interfering (DI) SFV. DI SFV was prepared by eight passages at high m.o.i, in BHK zI cells. Mice were treated with unpurified, unconcentrated tissue culture fluid which had been u.v.-irradiated to inactivate the infective virus present. Prevention of death was maximal when the DI virus was administered simultaneously with the infecting inoculum, and under the same conditions multiplication of infective virus in the brains of treated mice was reduced by IC-fold. It was shown that DI SFV was propagated in mouse brains following intranasal inoculation and it was concluded that protection was brought about through the intrinsic interfering capacity of the DI virus.
INTRODUCTION
Defective-interfering (DI) virus is produced during the multiplication of many different viruses (Huang, r973) . DI viruses are non-infective and multiply only with the assistance of 'standard' infective virus, hereafter referred to as standard virus. This results in decreased production of infective progeny or ' interference'. DI virus is dependent upon and interferes only with the multiplication of the parental virus or a closely related strain.
In the majority of instances DI viruses have been generated in cell culture but DI forms of influenza (von Magnus, I95 I), Rift Valley fever (Mims, t956) , lymphocytic choriomeningitis (Lehmann-Grube, I97 0, vesicular stomatitis and rabies viruses (Holland & Villarreal, I975) occur in vivo in embryonated chickens' eggs or in mice. There is speculation that DI viruses may have a biological role in the modulation of virus diseases (Huang & Baltimore, I97o) , but the only evidence for this has been the protection of mice lethally infected with vesicular stomatitis virus (VSV) by very high doses of DI VSV in adult and neonatal mice (Holland & Doyle, ~973; Doyle & Holland, I973; Holland & Villarreal, I975) . However, DI VSV could not be produced or perpetuated in adult mice although the protection afforded by DI VSV was greater in adults than in the neonates.
Recent studies have provided much information about the molecular biology of the defective-interfering particles of Semliki Forest virus (DI SFV; Bruton & Kennedy, i976; Bruton et al. I976) . DI SFV produced in BHK 2I cells has RNA which lacks a considerable portion of the central genomic region of standard SFV and interferes efficiently with the multiplication of standard SFV in BHK 2I cells. This report describes experiments which investigate the capacity of DI SFV to moderate the disease caused by intranasal infection of adult mice by standard SFV.
METHODS

Virus and cells.
Three times plaque-purified ts ÷ SFV (standard virus) and the extracellular fluids harvested after eight passages in BHK 2i cells at a constant multiplicity of 5 ° p.f.u./ cell (passage 8 virus) were those described by Bruton & Kennedy (I976) . These virus preparations were clarified by centrifuging at IOOOOg for 3o rain at 4 °C and stored at -70 °C. Monolayer cultures of BHK 2I cells, clone I3, and of primary chick embryo fibroblasts were grown in 5 cm plastic Petri dishes as described by Morser et al. (I973) .
Infectivity assays. The infectivity of SFV-containing samples was determined by plaque assay on chick embryo fibroblasts as described before (Kennedy & Burke, I972) except that o.o2 ~ DEAE-dextran was included in the agar overlay and the incubation temperature was 3 ° °C. These measures increased the size of plaques.
Mice. Random-bred mice of the Porton strain were purchased from Allington Farm, Porton and were used about I week after delivery. Male mice weighing about 2I g were used at approx. 5 weeks of age.
Infection. All mice were infected intranasally. Individual mice were anaesthetized with ether until just unconscious. A measured volume (20/zl) was delivered with a micropipette on to the nose which the mice then sniffed up into both nostrils. Mice were examined twice daily for signs of sickness, paralysis or death up to Io days after infection. When tissue samples were required mice were killed with ether. Blood was obtained from the heart before removing other organs and allowed to clot overnight at 4 °C. Lungs were washed in PBS. Olfactory bulbs were dissected out after removing the top of the skull. Lungs, olfactory bulbs and brain (less olfactory bulbs) were dispersed in medium I99 containing 5 % calf serum and stored at -70 °C. (u.v.) irradiation. One ml portions of virus suspension in 5 cm plastic Petri dishes were continuously agitated at room temperature in a position zo cm beneath an ultraviolet lamp (Anderman and Co. Ltd, London) for the times specified in individual experiments. The emission wavelength of the lamp was 256 nm and the dosage was 6o ergs/s/ cmL After irradiation samples were stored at -7o °C.
Ultraviolet
Measurement of virus-specified RNA and of the interference index of DIparticles. Preparations containing standard virus or DI particles, which on occasions were supplemented with standard virus, were used to infect BHK monolayer cultures at a m.o.i, of about IO p.f.u./ cell. The monolayers were previously labelled for i6 h with 2 #Ci/culture of ~H-uridine. After adsorption for I h at 37 °C the inocula were replaced with Glasgow modified MEM containing one-tenth the normal phosphate concentration, I #g/ml actinomycin D, 2o mM-HEPES (pH 7'4) and 2 ~o dialysed calf serum. After a further I h at 37 °C the fluids were removed, the cultures washed twice with warmed phosphate-free Earles's solution containing I #g/ml actinomycin D, ao mM-HEPES (pH 7'4) and 2 ~o dialysed calf serum and each culture incubated in 2 ml of this medium containing o'5 mCi 32P-orthophosphate/ml for a further 6 h. The cultures were then washed three times with ice-cold PBS, once with 5 ° mM-tris (pH 7"4) containing Ioo mM-NaC1 and I mM-EDTA (TNE) and the cell cytoplasm solubilized by incubating the monolayers under z ml TNE containing 2% (w/v) Triton NIoI for 2 min at room temperature. Each cytoplasmic extract was carefully removed (leaving the nuclei attached to the plastic dish), made to 2 % in SDS and a total nucleic acid extract was prepared as described by Bruton & Kennedy (i975) . The extract was alcohol precipitated at -20 °C in the presence of IOO #g carrier t-RNA. After recovery from alcohol by centrifuging and drying in a stream of N2, the extracts were counted and approx, equal amounts of each extract (as measured by aH-uridine radioactivity) were analysed on a 1.7 % (w/v) acrylamide + o. 13 % bisacrylamide + o.5 % agarose gel which was prepared and run as described before (Clegg & Kennedy, 1974) . After electrophoresis the gels were dried under vacuum at 9o °C and autoradiographed on Kodirex X-ray film for I to 3 days. The autoradiographs were then scanned using a Joyce-Loebl microdensitometer and the total areas under the RNA peaks corresponding to (A) standard virusspecified RNA species (42S, 38S, 33S and 26S RNA) and (B) DI particle species (DIssl and Dlssz) were determined (Bruton et al. 1976 ). The ratio B/A will be referred to as the interference index (but does not necessarily reflect any interference occurring in vivo). Radioimmunoassay. A modification of the technique described by Dalrymple et al. (1972) was used. Specifically, IO #1 portions of 35S-methionine labelled purified SFV [approx. o'oo5 #g, 15oo ct/min and prepared as described by Kennedy (I974) but using methioninedeficient culture medium] was mixed with twofold dilutions in triplicate of test antigen (5o #1) and 5o #1 of a iooo-fold dilution of SFV-specific, kaolin adsorbed antibody prepared in rabbits as described before (Kennedy, 1974) . This contained antibody to the envelope but not the core antigens. All dilutions were done using PBS lacking Ca 2+ and Mg 2+ ions. After incubation for I h at 37 °C, 5o #1 of goat anti-rabbit IgG was added to each sample and incubation continued for I h at 37 °C and then for 16 h at 4 °C. This was centrifuged at 7ooog for IO min at 4 °C and IOO #1 of each supernatant fluid was removed for counting, as was the remaining mixture of supernatant fluid and precipitate. The extent of precipitation was calculated from the difference in radioactivity between these two samples based upon the mean of the triplicate assays of each test antigen dilution. All samples were dissolved in o.I ml soluene-35o (Packard Instrument Co., Illinois, U.S.A.) and counted as previously described (Atkins et al. I974b) . The dilution of test antigen which gave 5o% precipitation was determined by interpolation. Controls were included in all assays by omission from the complete assay mixture of (i) test antigen, (ii) specific antibody and (iii) goat anti-rabbit IgG. In another control the complete mixture was prepared with preimmune antibody in place of specific antibody. In no case was non-specific precipitation greater than 5 %. The relationship between total antigenic mass and infectivity of SFV is shown in Fig. I . From this graph the total antigenic mass of virus preparations either containing or devoid of DI particles was converted into 'p.f.u. equivalents' (see below). Preliminary experiments showed that ultraviolet irradiation of standard SFV for 200 s did not measurably alter its ability to combine with antibody.
Since the infectivity titre of standard virus was known, the dilution which reduced precipitation of labelled SFV by 5o % could also be expressed as p.f.u. In order to equate the antigen present in the passage 8 virus with standard virus, the dilution of passage 8 virus which reduced precipitation by 5o% was determined and expressed in terms of 'p.f.u equivalents'. Thus passage 8 virus reduced precipitation of the radio-labelled SFV by 5o % at a dilution 35o-fold less than standard virus and therefore contained 35o-fold fewer 'p.f.u. equivalents' than standard virus.
RESULTS
Multiplication of virus after intranasal inoculation
Three mice were sacrificed at intervals after infection with standard SFV and the infectivity present in serum, lungs, brain (less olfactory bulbs) and olfactory bulbs was titrated. lungs until Iz h post infection (p.i.) and then remained at lO 2 to Io z p.f.u./g tissue. The level of virus/ml serum was similar but was not detected until 3 days p.i. In contrast there was a rapid increase to 1o 7 p.f.u./g in the olfactory bulbs between I2 and 24 h p.i. Infectivity in the brain rose more slowly and only exceeded that of the olfactory bulbs after 3 days. Similar results were also obtained with intranasal administration of Sindbis virus which suggests that in Porton mice these viruses are transmitted from the nose to the olfactory bulb and then to the brain. An alternative interpretation that virus infects some other organ first, enters the blood stream and then infects the CNS was not supported by experiments in which mice were infected via the tail vein, The resulting pattern of infection differed from that following intranasal administration since virus appeared first in the serum and then in the brain and lastly in the olfactory bulbs, essentially as reported by Bradish et al. (1975) .
In the succeeding experiments we attempted to protect SFV-infected mice with DI SFV. Since DI SFV does not direct the synthesis of virus proteins (Bruton et al. 1976 ) and therefore consists of virus components made entirely by standard SFV, it is likely that DI SFV follows the same route of infection as the standard virus. Hence we administered DI SFV by the intranasal route as it seemed to offer a direct access to the main site of virus multiplication in the brain. Fig. 3 . Effect of u.v. irradiation on the infectivity of SFV and on the interference index of passage 8 SFV. Separate ~ ml portions of SFV and passage 8 SFV were irradiated for various times as described in Methods. Each irradiated SFV sample (]oo #1) was then plaque assayed (O--O) and from the results of the plaque assay standard virus was added to half of each irradiated sample of passage 8 virus so that its infectivity might be restored to that of non-irradiated passage 8 virus. The interference index of these samples (A--A) together with that of the remaining irradiated samples not supplemented with standard virus (A--A) was determined.
Lethality of passage 8 SFV
Preliminary experiments indicated that for standard virus there were 6 x IO 2 p.f.u, per LDso when inoculated by the intranasal route. Passage 8 virus contains DI SFV together with about lO 6 p.f.u./ml infective SFV (Bruton & Kennedy, I976 ) . Titration of this material in mice by the intranasal (or intracerebral) route gave a pattern of infection and a p.f.u. per LDs0 similar to that of standard virus alone. Clearly this combination of standard virus and DI SFV was not moderating the infection and could not be used in protection experiments.
Effect of u.v.-irradiation on infectivity and
interfering capacity of DI SFV Fig. 3 shows that infectivity of SFV falls by over 6 log10 units in 6o s. Since we proposed to use an irradiated passage 8 preparation in protection experiments, we needed to show that it still possessed interfering capacity. Accordingly, after irradiation the infectivity was restored to its original value by the addition of an appropriate amount of standard virus. The interference index for BHK cells was then measured as described in Methods. There was no significant drop in interference index until after I8O s irradiation (Fig. 3) despite an assertion to the contrary by Huang (x973)-
In the following experiments infective virus present in passage 8 SFV preparations was inactivated by irradiation for Ioo s. This is then referred to as 'u.v. DI SFV'.
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Prevention of death in SFV-#~fected mice by u.v. DI SFV
In the following experiments mice were inoculated intranasally with Io LDs0 of standard SFV (6 x io 3 p.f.u.). Groups were treated with u.v. DI SFV (2 x lO 5 'p.f.u. equivalents') or an equivalent amount of u.v. standard SFV, estimated by the radioimmunoassay described in Methods. Treatments were given at 2 h before infection, at infection and 4 and 23 h p.i. The progress of the disease is recorded in Table I in terms of the number of sick, paralysed and dead mice. To summarize, of mice given standard SFV alone, Ioo% died; of those given u.v. standard SFV in addition, 80% died; of those given u.v. DI SFV in addition, 15% died. This crucial experiment was repeated on several occasions and the following generalizations emerged: (I) administration of u.v. DI SFV as described above always protected infected mice to the extent that over 50 % survived. (2) If infected mice treated with u.v. DI SFV became ill they always died. On no occasion did a sick or paralysed mouse recover. (3) When an infected mouse treated with u.v. DI SFV became sick the progress of the disease and its symptoms were always within the range observed for mice given only standard SFV. (4) The pattern of disease in infected mice treated with u.v. standard SFV differed in no way from that in mice given only SFV except that, on occasion, a few mice would survive. This varied between o and 2o %.
We concluded that the DI SFV preparation was in some way modifying the lethal effect of SFV and proceeded to investigate how the DI virus preparation was involved.
Effect of u.v. DI SFV on multiplication of standard SFV in mice
Infection and treatments were carried out as described above. Control mice which received diluent, u.v. DI SFV (2 x IO n 'p.f.u. equivalents' per dose) or u.v. standard SFV remained healthy (Table 2 ). No infective virus was isolated from them showing that the inactivation had been effective (and that cage-to-cage transmission did not take place). All mice given SFV alone had high virus infectivity in olfactory bulbs and in the rest of 3"4 Well 6.8 9"4 Paralysed * All mice were inoculated intranasally as before. Infected mice received 1o LD~0. Those treated with u.v. SFV or u.v. DI SFV (2 × IO ~ 'p.f.u. equivalents ') were inoculated at 2 h before, at infection and 4 and 23 h after infection. Mice were killed 4 days after infection. Results are expressed as Iogz 0 p.f.u./mouse. the brain. Titres of virus from infected mice treated with u.v. standard SFV were in the same range. At the time the experiment was terminated some mice in each of these two categories were still healthy, some sick, while others were paralysed; these differences were not reflected by virus infectivity in the brains. Three out of four infected mice treated with u.v. DI SFV remained well. Brain titres were reduced by about 5 log10 units and olfactory bulb titres by about 3 log10 units. Infectious virus could not be isolated from one mouse. Lastly, one u.v. DI SFV treated mouse was paralysed; titres of infective virus in its olfactory bulbs and brain were typical of mice having SFV alone. We concluded that the treatment of infected mice with u.v. DI SFV but not u.v. standard SFV could reduce virus multiplication to a high degree.
Effect of number of doses of u.v. DI SFV on standard SFV-infected mice
Initially mice were treated with an empirically derived schedule at 2 h before, at infection and 4 and 24 h after infection which proved to be effective. Later experiments were designed to test the effects of each of these inocula (Table 3 ). The most effective single administration of u.v. DI virus was together with the infecting virus. However, prevention of death was more efficient with an additional pre-infection inoculation with DI virus. This treatment proved to be as effective as the full course. DI virus administered at 4 and 24 h after standard virus was of no benefit to the mice. Table 4 shows that undiluted u.v. DI SFV prevented death in 8o % of mice inoculated with io LDs0 of standard virus. However this protection was lost when u.v. DI SFV was diluted Io-fold. Protection was also reduced when mice were given IOO LD~ 0 and undiluted u.v. t Boxes show protection of >I 2o% (3/15) mice over a period of 3 or more days. :~ Groups of I5 mice were treated with u.v. DI SFV at z h before infection and at infection.
Prevention of death in mice infected with increasing amounts of standard SFV by decreasing amounts of u.v. DI SFV
DI SFV and no protection was obtained against infection with Iooo LDso. Thus, to prevent death by Io LDs0 we require a ratio of at least 67 'p.f.u. equivalents' DI SFV to I p.f.u. standard SFV, while with Ioo LDs0 a ratio of 6"7 gave some protection.
Effect of varying the time of administration o]" u.v. DI SFV on standard SFV-infected mice
There was no doubt that treatment of mice with u.v. DI SFV (2 × Io 5 'p.f.u. equivalents') at 8, 2 or even I h before infection had no effect on the course of disease or time of death of infected mice. Similarly u.v. DI SFV administered at I h or later after infection did not alter the course of disease. Onset of illness was delayed by about 24 h when u.v. DI SFV was given 3o min following infection but by day 5 the normal extent of disease was evident.
BHK cells were also pre-treated with u.v. DI SFV at various times before standard virus was added at time o. Propagation of DI virus was measured as described in Methods.
DI virus was detected in cells inoculated with u.v. DI SFV at 2 and 4 h but not at 6, 8 or I2 h before addition of standard virus.
Mode of action of protection by u.v. DI SFV Interference with attachment of infectious virus ?
Prevention of death was most efficient with 67-fold excess DI SFV over standard infective virus. If the number of attachment sites was limited it could be suggested that DI virus was physically preventing standard virus from adsorbing to and infecting cells. However the failure of an amount of u.v. standard SFV equivalent to DI SFV to protect mice indicated that this was not the explanation.
Induction of interferon ?
The induction of interferon by DI SFV in chick embryo cells in culture at 24 h after infection was abolished progressively by u.v.-irradiation and after IOO s no interferon could be detected by the method of Atkins et al. 0974a). Mice were tested for the induction of interferon by four intranasal inoculations of u.v. DI SFV (containing no infective virus) at o, 2, 6 and 24 h. No interferon could be detected in serum collected at 8 and 3 x h.
The absence of detectable serum interferon did not mean that interferon was not being produced and exerting an inhibitory effect in some localized site in the mouse. Sindbis virus was the most suitable probe for detecting local interferon since after intranasal inoculation Sindbis could be found at high levels in the olfactory bulbs and then the brain with kinetics of appearance similar to those of SFV.
Sindbis and u.v. DI SFV were inoculated together and the infectivity present in the brain and olfactory bulbs at 4 days after infection was titrated. Neither u.v. DI SFV or u.v. standard SFV inhibited the multiplication of Sindbis virus. Together these results indicate that interferon played no detectable part in the protection by u.v. DI SFV described in this report.
Interference by the production of defective-interfering virus
In order to postulate that mice survived a lethal SFV infection through the interfering property of DI SFV it is necessary to demonstrate that u.v. DI SFV is propagated in mice inoculated intranasally. Mice were given a single dose of u.v. DI SFV (z × Io 5 'p.f.u. equivalents') in 3 x io 6 p.f.u. Controls consisted of mice inoculated with 3 x io 6 p.f.u. alone. Brains (+ olfactory bulbs) were harvested after 3 days and were assayed for the presence of DI SFV by the enhanced DI SFV RNA assay described in Methods. Results in Table 5 show that D[ SFV RNA was present only in brains of mice inoculated with u.v. DI SFV. A control was devised to see if the assay would detect the amount of u.v. DI SFV present in the mouse inoculum if it had not been propagated. This consisted of a mouse brain homogenate mixed (a) with the mouse inoculum (u.v. DI SFV+standard SFV as above) or (b) with z × ~o 9 p.f.u, standard SFV which is the level of virus in the brain after it has multiplied for 3 days. These mixtures were then assayed by the enhanced DI SFV RNA system and no DI SFV RNA was detected. Thus we conclude that DI SFV was propagated in the brains of infected mice following intranasal inoculation. 
DISCUSSION
Our data suggest that standard SFV, inoculated in a drop on to the nose, infects the CNS via the olfactory nerves. The precise cellular route by which viruses may scale the olfactory nerve is discussed by Johnson & Mims (I968) . The accounts of aerosol infection of hamsters with SFV (Henderson et al. I967 ) and of mice with West Nile virus (Nit et al. I965) are also particularly relevant here. It seems likely that intranasal infections follow specific routes since, for example, herpes simplex virus type I appears preferentially in the trigeminal nerve compared with the olfactory bulbs (Rabin et al. I968) .
Using the intranasal route we have demonstrated that exogenously applied DI virus can prevent the appearance of disease and eventual death which results from infection with Semliki Forest virus. We could detect no production of interferon in response to the u.v. DI virus administered. DI virus was propagated under the conditions used. The effect on the immune system of administering a total of 8 × Io 5 'p.f.u. equivalents' of u.v. DI SFV was not fully investigated. However, preliminary experiments in which mice were immunosuppressed with cyclophosphamide (2oo mg/kg) at the time of infection showed that protection by u.v. DI SFV was as effective as in mice not given the drug (data not shown). We conclude therefore that the prevention of disease and death was due to the intrinsic interference of the defective-interfering virus. This was borne out by our finding that after treatment with DI virus there was a Io 4 to ~oS-fold reduction of infectious virus in the brains of those infected mice which showed no signs of illness. Although we were able to protect the majority of infected mice with DI virus there were always some which succumbed. The clinical signs, time of death and amount of infectious virus present showed that DI virus did not ameliorate the disease to any noticeable extent. Since protected mice had low virus titres in olfactory bulbs it seems that interference with virus multiplication took place at this location or between the olfactory bulbs and a putative primary site of infection in the nose.
Protection by other DI viruses in animals has been demonstrated in mice with DI (yon Magnus) influenza virus inoculated intranasally (yon Magnus, 195I), and DI VSV inoculated intracerebrally (Doyle & Holland, I973; Holland & Doyle, ~973; Holland & Villarreal, i975) . It is not certain that protection was afforded by the interfering capacity of yon Magnus virus as the existence and possible involvement of interferon was not known at that time.
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Treatment of infected mice with DI SFV
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Holland and co-workers failed to demonstrate protection via the intranasal route with DI influenza virus, but the p.f.u. : HA ratio of infective virus found in the lungs of treated mice was less than with untreated, showing that interference had taken place. DI VSV fails to protect when given intranasally (Holland & Doyle, I973) whereas the same amount of DI VSV does protect when administered intracerebrally; this probably reflects the larger (about Io3-fold) intranasal inoculum of infective virus. It would be interesting to see if mice could be protected with DI VSV from smaller doses of infective virus in the light of our findings in this report.
Several points arise in a comparison between Doyle & Holland's 0973) successful protection of mice with Dt VSV and also ours with DI SFV. Firstly, these findings establish that protection by DI viruses in vivo can occur with both negative (VSV) and positive (SFV) stranded RNA viruses. However, it is not completely clear that the protection afforded by DI VSV is due to its intrinsic interfering capacity since the best protection in adult mice is not accompanied by generation or perpetuation of DI virus (Holland & Villarreal, I975) . Secondly, while Io 1° purified DI particles were required per mouse for protection in VSV infections (Holland & Doyle, 1973; Holland & Villarreal, I975) , we were able to use unpurified DI SFV present in tissue culture fluids. Thirdly, protection has now been demonstrated by both the intracerebral route (Holland and co-workers) and the intranasal route.
Although the latter cannot be described as a natural route of infection, apriori it causes less trauma and approximates more closely to natural infection than crushing a hole through the skull! A major problem in the therapeutic use of DI virus is introducing it into cells containing multiplying virus. This is probably the reason why we failed to propagate DI SFV by injecting DI virus into the brains of mice when over IO ~ p.f.u, were present (data not shown). The problem is aggravated if the infecting virus departs from the initial superficial site of injection. This was apparently the reason why we failed to obtain protection with DI SFV administered after infection. Prophylaxis was also ineffective although this may reflect degradation of the DI virus since 'prophylaxis' of BHK cells was limited to 4hprior to infection.
We feel that the small amount of DI virus required for protection, the use of u.v.-irradiation to remove infective virus and the use of unpurified tissue culture fluids encourages the investigation of the possible therapeutic use of DI virus in situations where the site of infection is known and there exists a way of delivering the DI virus to that site. The convenience of intranasal/aerosol administration suggests that respiratory infections might be particularly suitable for study.
